-
1
-
-
78349242855
-
Puralpha and nucleotide excision repair system: Implications in cellular response to ultraviolet C radiation-induced DNA damage and chemoresistance in malignant cells
-
Romano G, Giordano A, (2010) Puralpha and nucleotide excision repair system: Implications in cellular response to ultraviolet C radiation-induced DNA damage and chemoresistance in malignant cells. Cell Cycle 9: 4262.
-
(2010)
Cell Cycle
, vol.9
, pp. 4262
-
-
Romano, G.1
Giordano, A.2
-
2
-
-
49649104978
-
Mechanisms of chemoresistance to alkylating agents in malignant glioma
-
Sarkaria JN, Kitange GJ, James CD, Plummer R, Calvert H, et al. (2008) Mechanisms of chemoresistance to alkylating agents in malignant glioma. Clin Cancer Res 14: 2900-2908.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 2900-2908
-
-
Sarkaria, J.N.1
Kitange, G.J.2
James, C.D.3
Plummer, R.4
Calvert, H.5
-
3
-
-
16544374489
-
Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review)
-
Wang G, Reed E, Li QQ, (2004) Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review). Oncol Rep 12: 955-965.
-
(2004)
Oncol Rep
, vol.12
, pp. 955-965
-
-
Wang, G.1
Reed, E.2
Li, Q.Q.3
-
4
-
-
77958520845
-
Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel
-
Hoskins P, Vergote I, Cervantes A, Tu D, Stuart G, et al. (2010) Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel. J Natl Cancer Inst 102: 1547-1556.
-
(2010)
J Natl Cancer Inst
, vol.102
, pp. 1547-1556
-
-
Hoskins, P.1
Vergote, I.2
Cervantes, A.3
Tu, D.4
Stuart, G.5
-
5
-
-
0015383455
-
Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics
-
Kerr JF, Wyllie AH, Currie AR, (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257.
-
(1972)
Br J Cancer
, vol.26
, pp. 239-257
-
-
Kerr, J.F.1
Wyllie, A.H.2
Currie, A.R.3
-
6
-
-
0035736259
-
Organelle-specific initiation of cell death pathways
-
Ferri KF, Kroemer G, (2001) Organelle-specific initiation of cell death pathways. Nat Cell Biol 3: E255-E263.
-
(2001)
Nat Cell Biol
, vol.3
-
-
Ferri, K.F.1
Kroemer, G.2
-
7
-
-
0034682695
-
Mitochondria-the death signal integrators
-
Apoptosis
-
Brenner C, Kroemer G, (2000) Apoptosis (2000) Mitochondria-the death signal integrators. Science 289: 1150-1151.
-
(2000)
Science
, vol.289
, pp. 1150-1151
-
-
Brenner, C.1
Kroemer, G.2
-
8
-
-
0036308059
-
Mitochondria, the killer organelles and their weapons
-
Ravagnan L, Roumier T, Kroemer G, (2002) Mitochondria, the killer organelles and their weapons. J Cell Physiol 192: 131-137.
-
(2002)
J Cell Physiol
, vol.192
, pp. 131-137
-
-
Ravagnan, L.1
Roumier, T.2
Kroemer, G.3
-
9
-
-
2342635919
-
Cell death by mitotic catastrophe: a molecular definition
-
Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, et al. (2004) Cell death by mitotic catastrophe: a molecular definition. Oncogene 23: 2825-2837.
-
(2004)
Oncogene
, vol.23
, pp. 2825-2837
-
-
Castedo, M.1
Perfettini, J.L.2
Roumier, T.3
Andreau, K.4
Medema, R.5
-
10
-
-
0037484271
-
Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents
-
Xiao Z, Chen Z, Gunasekera AH, Sowin TJ, Rosenberg SH, et al. (2003) Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents. J Biol Chem 278: 21767-21773.
-
(2003)
J Biol Chem
, vol.278
, pp. 21767-21773
-
-
Xiao, Z.1
Chen, Z.2
Gunasekera, A.H.3
Sowin, T.J.4
Rosenberg, S.H.5
-
11
-
-
48249092713
-
DNA damage detection and repair pathways-recent advances with inhibitors of checkpoint kinases in cancer therapy
-
Ashwell S, Zabludoff S, (2008) DNA damage detection and repair pathways-recent advances with inhibitors of checkpoint kinases in cancer therapy. Clin Cancer Res 14: 4032-4037.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 4032-4037
-
-
Ashwell, S.1
Zabludoff, S.2
-
12
-
-
78650618910
-
Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression
-
Berghuis D, Santos SJ, Baelde HJ, Taminiau AH, Egeler RM, et al. (2011) Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression. J Pathol 223: 347-357.
-
(2011)
J Pathol
, vol.223
, pp. 347-357
-
-
Berghuis, D.1
Santos, S.J.2
Baelde, H.J.3
Taminiau, A.H.4
Egeler, R.M.5
-
13
-
-
78649637459
-
Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy
-
Mishra P, Banerjee D, Ben-Baruch A, (2011) Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy. J Leukoc Biol 89: 31-39.
-
(2011)
J Leukoc Biol
, vol.89
, pp. 31-39
-
-
Mishra, P.1
Banerjee, D.2
Ben-Baruch, A.3
-
14
-
-
33645509280
-
A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer
-
Wang B, Hendricks DT, Wamunyokoli F, Parker MI, (2006) A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer. Cancer Res 66: 3071-3077.
-
(2006)
Cancer Res
, vol.66
, pp. 3071-3077
-
-
Wang, B.1
Hendricks, D.T.2
Wamunyokoli, F.3
Parker, M.I.4
-
15
-
-
58249102852
-
Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis
-
Cataisson C, Ohman R, Patel G, Pearson A, Tsien M, et al. (2009) Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis. Cancer Res 69: 319-328.
-
(2009)
Cancer Res
, vol.69
, pp. 319-328
-
-
Cataisson, C.1
Ohman, R.2
Patel, G.3
Pearson, A.4
Tsien, M.5
-
16
-
-
67650034624
-
CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer
-
Matsuo Y, Raimondo M, Woodward TA, Wallace MB, Gill KR, et al. (2009) CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer. Int J Cancer 125: 1027-1037.
-
(2009)
Int J Cancer
, vol.125
, pp. 1027-1037
-
-
Matsuo, Y.1
Raimondo, M.2
Woodward, T.A.3
Wallace, M.B.4
Gill, K.R.5
-
17
-
-
35348829769
-
Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis
-
Furuya M, Suyama T, Usui H, Kasuya Y, Nishiyama M, et al. (2007) Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis. Hum Pathol 38: 1676-1687.
-
(2007)
Hum Pathol
, vol.38
, pp. 1676-1687
-
-
Furuya, M.1
Suyama, T.2
Usui, H.3
Kasuya, Y.4
Nishiyama, M.5
-
18
-
-
33646255924
-
High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras
-
Wislez M, Fujimoto N, Izzo JG, Hanna AE, Cody DD, et al. (2006) High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. Cancer Res 66: 4198-4207.
-
(2006)
Cancer Res
, vol.66
, pp. 4198-4207
-
-
Wislez, M.1
Fujimoto, N.2
Izzo, J.G.3
Hanna, A.E.4
Cody, D.D.5
-
19
-
-
33750798741
-
The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis
-
Yang G, Rosen DG, Zhang Z, Bast RC Jr, Mills GB, et al. (2006) The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc Natl Acad Sci U S A 103: 16472-16477.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 16472-16477
-
-
Yang, G.1
Rosen, D.G.2
Zhang, Z.3
Bast Jr., R.C.4
Mills, G.B.5
-
20
-
-
0032562614
-
Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration
-
White JR, Lee JM, Young PR, Hertzberg RP, Jurewicz AJ, et al. (1998) Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem 273: 10095-10098.
-
(1998)
J Biol Chem
, vol.273
, pp. 10095-10098
-
-
White, J.R.1
Lee, J.M.2
Young, P.R.3
Hertzberg, R.P.4
Jurewicz, A.J.5
-
21
-
-
54249146562
-
The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice
-
Bento AF, Leite DF, Claudino RF, Hara DB, Leal PC, et al. (2008) The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice. J Leukoc Biol 84: 1213-1221.
-
(2008)
J Leukoc Biol
, vol.84
, pp. 1213-1221
-
-
Bento, A.F.1
Leite, D.F.2
Claudino, R.F.3
Hara, D.B.4
Leal, P.C.5
-
22
-
-
16444371504
-
IL-8 increases transmission of HIV type 1 in cervical explant tissue
-
Narimatsu R, Wolday D, Patterson BK, (2005) IL-8 increases transmission of HIV type 1 in cervical explant tissue. AIDS Res Hum Retroviruses 21: 228-233.
-
(2005)
AIDS Res Hum Retroviruses
, vol.21
, pp. 228-233
-
-
Narimatsu, R.1
Wolday, D.2
Patterson, B.K.3
-
23
-
-
34547670601
-
ELR+-CXC chemokines and their receptors in early metanephric development
-
Levashova ZB, Sharma N, Timofeeva OA, Dome JS, Perantoni AO, (2007) ELR+-CXC chemokines and their receptors in early metanephric development. J Am Soc Nephrol 18: 2359-2370.
-
(2007)
J Am Soc Nephrol
, vol.18
, pp. 2359-2370
-
-
Levashova, Z.B.1
Sharma, N.2
Timofeeva, O.A.3
Dome, J.S.4
Perantoni, A.O.5
-
24
-
-
71849088630
-
Structural optimization of a CXCR2-directed antagonist that indirectly inhibits gamma-secretase and reduces Abeta
-
Bakshi P, Jin C, Broutin P, Berhane B, Reed J, et al. (2009) Structural optimization of a CXCR2-directed antagonist that indirectly inhibits gamma-secretase and reduces Abeta. Bioorg Med Chem 17: 8102-8112.
-
(2009)
Bioorg Med Chem
, vol.17
, pp. 8102-8112
-
-
Bakshi, P.1
Jin, C.2
Broutin, P.3
Berhane, B.4
Reed, J.5
-
25
-
-
0242610903
-
p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells
-
Fraser M, Leung BM, Yan X, Dan HC, Cheng JQ, et al. (2003) p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells. Cancer Res 63: 7081-7088.
-
(2003)
Cancer Res
, vol.63
, pp. 7081-7088
-
-
Fraser, M.1
Leung, B.M.2
Yan, X.3
Dan, H.C.4
Cheng, J.Q.5
-
26
-
-
37349060695
-
Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function
-
Fraser M, Bai T, Tsang BK, (2008) Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function. Int J Cancer 122: 534-546.
-
(2008)
Int J Cancer
, vol.122
, pp. 534-546
-
-
Fraser, M.1
Bai, T.2
Tsang, B.K.3
-
27
-
-
33645516362
-
Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway
-
Yang X, Fraser M, Moll UM, Basak A, Tsang BK, (2006) Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway. Cancer Res 66: 3126-3136.
-
(2006)
Cancer Res
, vol.66
, pp. 3126-3136
-
-
Yang, X.1
Fraser, M.2
Moll, U.M.3
Basak, A.4
Tsang, B.K.5
-
28
-
-
49649110459
-
Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells
-
Abedini MR, Muller EJ, Brun J, Bergeron R, Gray DA, et al. (2008) Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells. Cancer Res 68: 4511-4517.
-
(2008)
Cancer Res
, vol.68
, pp. 4511-4517
-
-
Abedini, M.R.1
Muller, E.J.2
Brun, J.3
Bergeron, R.4
Gray, D.A.5
-
29
-
-
73849152723
-
Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein
-
Abedini MR, Muller EJ, Bergeron R, Gray DA, Tsang BK, (2010) Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein. Oncogene 29: 11-25.
-
(2010)
Oncogene
, vol.29
, pp. 11-25
-
-
Abedini, M.R.1
Muller, E.J.2
Bergeron, R.3
Gray, D.A.4
Tsang, B.K.5
-
30
-
-
84860286309
-
The oncogenic phosphatase PPM1D confers Cisplatin resistance in ovarian carcinoma cells by attenuating Checkpoint kinase 1 and p53 activation
-
Ali AY, Abedini MR, Tsang BK, (2012) The oncogenic phosphatase PPM1D confers Cisplatin resistance in ovarian carcinoma cells by attenuating Checkpoint kinase 1 and p53 activation. Oncogene 31: 2175-2186.
-
(2012)
Oncogene
, vol.31
, pp. 2175-2186
-
-
Ali, A.Y.1
Abedini, M.R.2
Tsang, B.K.3
-
31
-
-
37349060695
-
Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function
-
Fraser M, Bai T, Tsang BK, (2008) Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function. Internat. J Cancer. 122: 534-546.
-
(2008)
Internat. J Cancer
, vol.122
, pp. 534-546
-
-
Fraser, M.1
Bai, T.2
Tsang, B.K.3
-
32
-
-
0036047670
-
CD40L stimulation enhances the ability of conventional metaphase cytogenetics to detect chromosome aberrations in B-cell chronic lymphocytic leukaemia cells
-
Buhmann R, Kurzeder C, Rehklau J, Westhaus D, Bursch S, et al. (2002) CD40L stimulation enhances the ability of conventional metaphase cytogenetics to detect chromosome aberrations in B-cell chronic lymphocytic leukaemia cells. Br J Haematol 118: 968-975.
-
(2002)
Br J Haematol
, vol.118
, pp. 968-975
-
-
Buhmann, R.1
Kurzeder, C.2
Rehklau, J.3
Westhaus, D.4
Bursch, S.5
-
33
-
-
74849117332
-
Mitochondrial MDM4 (MDMX): an unpredicted role in the p53-mediated intrinsic apoptotic pathway
-
Mancini F, Moretti F, (2009) Mitochondrial MDM4 (MDMX): an unpredicted role in the p53-mediated intrinsic apoptotic pathway. Cell Cycle 8: 3854-3859.
-
(2009)
Cell Cycle
, vol.8
, pp. 3854-3859
-
-
Mancini, F.1
Moretti, F.2
-
34
-
-
34547153634
-
CDIP, a novel pro-apoptotic gene, regulates TNFalpha-mediated apoptosis in a p53-dependent manner
-
Brown L, Ongusaha PP, Kim HG, Nuti S, Mandinova A, et al. (2007) CDIP, a novel pro-apoptotic gene, regulates TNFalpha-mediated apoptosis in a p53-dependent manner. EMBO J 26: 3410-3422.
-
(2007)
EMBO J
, vol.26
, pp. 3410-3422
-
-
Brown, L.1
Ongusaha, P.P.2
Kim, H.G.3
Nuti, S.4
Mandinova, A.5
-
35
-
-
33845638436
-
p53-based cancer therapies: Is defective p53 the Achilles heel of the tumor?
-
Levesque AA, Eastman A, (2007) p53-based cancer therapies: Is defective p53 the Achilles heel of the tumor? Carcinogenesis 28: 13-20.
-
(2007)
Carcinogenesis
, vol.28
, pp. 13-20
-
-
Levesque, A.A.1
Eastman, A.2
-
36
-
-
22844436238
-
Chk1 is essential for tumor cell viability following activation of the replication checkpoint
-
Cho SH, Toouli CD, Fujii GH, Crain C, Parry D, (2005) Chk1 is essential for tumor cell viability following activation of the replication checkpoint. Cell Cycle 4: 131-139.
-
(2005)
Cell Cycle
, vol.4
, pp. 131-139
-
-
Cho, S.H.1
Toouli, C.D.2
Fujii, G.H.3
Crain, C.4
Parry, D.5
-
37
-
-
0035422203
-
Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells
-
Hirose Y, Berger MS, Pieper RO, (2001) Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells. Cancer Res 61: 5843-5849.
-
(2001)
Cancer Res
, vol.61
, pp. 5843-5849
-
-
Hirose, Y.1
Berger, M.S.2
Pieper, R.O.3
-
38
-
-
0030706078
-
UCN-01 in ovary cancer cells: effective as a single agent and in combination with cis-diamminedichloroplatinum(II) independent of p53 status
-
Husain A, Yan XJ, Rosales N, Aghajanian C, Schwartz GK, et al. (1997) UCN-01 in ovary cancer cells: effective as a single agent and in combination with cis-diamminedichloroplatinum(II) independent of p53 status. Clin Cancer Res 3: 2089-2097.
-
(1997)
Clin Cancer Res
, vol.3
, pp. 2089-2097
-
-
Husain, A.1
Yan, X.J.2
Rosales, N.3
Aghajanian, C.4
Schwartz, G.K.5
-
39
-
-
4644318231
-
Potentiation of cytotoxicity of topoisomerase i poison by concurrent and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic catastrophe
-
Tse AN, Schwartz GK, (2004) Potentiation of cytotoxicity of topoisomerase i poison by concurrent and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic catastrophe. Cancer Res 64: 6635-6644.
-
(2004)
Cancer Res
, vol.64
, pp. 6635-6644
-
-
Tse, A.N.1
Schwartz, G.K.2
-
40
-
-
0029895439
-
UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53
-
Wang Q, Fan S, Eastman A, Worland PJ, Sausville EA, et al. (1996) UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. J Natl Cancer Inst 88: 956-965.
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 956-965
-
-
Wang, Q.1
Fan, S.2
Eastman, A.3
Worland, P.J.4
Sausville, E.A.5
-
41
-
-
13944266820
-
The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair
-
Sorensen CS, Hansen LT, Dziegielewski J, Syljuasen RG, Lundin C, et al. (2005) The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair. Nat Cell Biol 7: 195-201.
-
(2005)
Nat Cell Biol
, vol.7
, pp. 195-201
-
-
Sorensen, C.S.1
Hansen, L.T.2
Dziegielewski, J.3
Syljuasen, R.G.4
Lundin, C.5
-
42
-
-
33749599776
-
Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase
-
Petermann E, Caldecott KW, (2006) Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase. Cell Cycle 5: 2203-2209.
-
(2006)
Cell Cycle
, vol.5
, pp. 2203-2209
-
-
Petermann, E.1
Caldecott, K.W.2
-
43
-
-
78650208984
-
Status of p53 in human cancer cells does not predict efficacy of CHK1 kinase inhibitors combined with chemotherapeutic agents
-
Zenvirt S, Kravchenko-Balasha N, Levitzki A, (2010) Status of p53 in human cancer cells does not predict efficacy of CHK1 kinase inhibitors combined with chemotherapeutic agents. Oncogene 29: 6149-6159.
-
(2010)
Oncogene
, vol.29
, pp. 6149-6159
-
-
Zenvirt, S.1
Kravchenko-Balasha, N.2
Levitzki, A.3
-
44
-
-
69249222632
-
SB265610 is an allosteric, inverse agonist at the human CXCR2 receptor
-
Bradley ME, Bond ME, Manini J, Brown Z, Charlton SJ, (2009) SB265610 is an allosteric, inverse agonist at the human CXCR2 receptor. Br J Pharmacol 158: 328-338.
-
(2009)
Br J Pharmacol
, vol.158
, pp. 328-338
-
-
Bradley, M.E.1
Bond, M.E.2
Manini, J.3
Brown, Z.4
Charlton, S.J.5
-
45
-
-
0036295256
-
CXCL8((3-73))K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8
-
Li F, Zhang X, Gordon JR, (2002) CXCL8((3-73))K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8. Biochem Biophys Res Commun 293: 939-944.
-
(2002)
Biochem Biophys Res Commun
, vol.293
, pp. 939-944
-
-
Li, F.1
Zhang, X.2
Gordon, J.R.3
-
46
-
-
67649600825
-
K-Ras promotes angiogenesis mediated by immortalized human pancreatic epithelial cells through mitogen-activated protein kinase signaling pathways
-
Matsuo Y, Campbell PM, Brekken RA, Sung B, Ouellette MM, et al. (2009) K-Ras promotes angiogenesis mediated by immortalized human pancreatic epithelial cells through mitogen-activated protein kinase signaling pathways. Mol Cancer Res 7: 799-808.
-
(2009)
Mol Cancer Res
, vol.7
, pp. 799-808
-
-
Matsuo, Y.1
Campbell, P.M.2
Brekken, R.A.3
Sung, B.4
Ouellette, M.M.5
|